Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 1, 2003, Pages 98-104

  Li, Chung Pin ^a   Chao, Yee ^a   Chi, Kwan Hwa ^a   Chan, Wing Kai ^a   Teng, Ho Chung ^a   Lee, Rheun Chuan ^a   Chang, Full Young ^a   Lee, Shou Dong ^a   Yen, Sang Hue ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

5 Fluorouracil; Chemoradiotherapy; Gemcitabine; Pancreatic cancer

Indexed keywords

BIOCHEMISTRY; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

CONCURRENT CHEMORADIOTHERAPY (CCRT);

ONCOLOGY;

ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; STOMACH EROSION; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION;

EID: 0042566185     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00435-8     Document Type: Article

References (25)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47.
2. Evans D.B., Abbruzzese J.L., Rich T.A. Cancer of the pancreas. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. 6th ed: 1998;1126-1161 Lippincott Williams & Wilkins, Philadelphia.
3. Moertel C.G., Frytak S., Hahn R.G., et al. Therapy of locally unresectable pancreatic carcinoma A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil . Cancer. 48:1981;1705-1710.
4. Plunkett W., Huang P., Searcy C.E., et al. Gemcitabine Preclinical pharmacology and mechanisms of action . Semin Oncol. 23:1996;3-15.
5. Burris H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer A randomized trial . J Clin Oncol. 15:1997;2403-2413.
6. Lawrence T.S., Chang E.Y., Hahn T.M., et al. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys. 34:1996;867-872.
7. Lawrence T.S., Eisbruch A., Shewach D.S. Gemcitabine-mediated radiosensitization. Semin Oncol. 24:1997;S7-S28.
8. Milas L., Fujii T., Hunter N., et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res. 59:1999;107-114.
9. Doyle T.H., Mornex F., McKenna W.G. The clinical implications of gemcitabine radiosensitization. Clin Cancer Res. 7:2001;226-228.
10. Hoffman J.P., McGinn C.J., Ross E., et al. A phase I trial of preoperative gemcitabine for patients with localized, resectable pancreatic adenocarcinoma. Cancer Invest. 17:1999;30-32.
11. Blackstock A.W., Bernard S.A., Richards F., et al. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol. 17:1999;2208-2212.
12. McGinn C.J., Zalupski M.M., Shureiqi I., et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 19:2001;4202-4208.
13. Epelbaum R., Rosenblatt E., Nasrallah S., et al. Phase II study of gemcitabine (GEM) combined with radiation therapy (RT) in localized, unresectable pancreatic cancer. [Abstract] Eur J Cancer. 35:1999;S148-S149.
14. Crane C.H., Wolff R.A., Abbruzzese J.L., et al. Combining gemcitabine with radiation in pancreatic cancer Understanding important variables influencing the therapeutic index . Semin Oncol. 28:2001;25-33.
15. Crane C.H., Abbruzzese J.L., Evans D.B., et al. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys. 52:2002;1293-1302.
16. Poggi M.M., Kroog G.S., Russo A., et al. Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 54:2002;670-676.
17. Hoffman J.P., McGinn C.J., Szarka C., et al. A phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PaC). [Abstract] Proc Am Soc Clin Oncol. 17:1998;283a.
18. Mustacchi G., Beorchia A., Milani S., et al. Gemcitabine (GEM), and concomitant radiation for locally advanced or relapsed pancreatic cancer. [Abstract] Proc Am Soc Clin Oncol. 20:2001;134b.
19. Kachnic L.A., Shaw J.E., Manning M.A., et al. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas. Int J Cancer. 96:2001;132-139.
20. NCCN practice guidelines for pancreatic cancer. Oncology. 11:1997;41-55.
21. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer. 56:1985;2563-2568.
22. Klaassen D.J., MacIntyre J.M., Catton G.E., et al. Treatment of locally unresectable cancer of the stomach and pancreas A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - An Eastern Cooperative Oncology Group study . J Clin Oncol. 3:1985;373-378.
23. Pipas J.M., Mitchell S.E., Barth R.J. Jr, et al. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 50:2001;1317-1322.
24. Talamonti M.S., Catalano P.J., Vaughn D.J., et al. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer A regimen with unexpected early toxicity . J Clin Oncol. 18:2000;3384-3389.
25. Wolff R.A., Evans D.B., Gravel D.M., et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res. 7:2001;2246-2253.